More Business Wire
View Older Stories View Newer Stories-
Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering
-
Calluna Pharma Announces the Appointment of Gijs van den Brink, MD, PhD, as Independent Director
-
Black Hat Europe 2025: "The Future of Cybersecurity is Now" – Keynotes, Summits, and Breakthrough Innovations Shape the Industry
-
Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline
-
Koard Now Offers Tap to Pay on iPhone for Merchants to Accept Contactless Payments
-
Mainstreet Equity Posts Double-Digit Year-Over-Year Growth in FY2025
-
Mitsubishi Electric Technology Detects Intoxication During Driving to Provide Driver Alerts and Even Vehicle-control Interventions
-
Mitsubishi Electric to Participate in FIBA 3x3 Women’s Series as First Japanese Company
-
Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace
-
THE LITTLE CATHOLIC Announces a New Chapter of Growth, Craftsmanship, and Devotional Beauty
-
STEP Energy Services Ltd. Announces Receipt of Final Order
-
FutureNexus Labs Inc. Launches NeigborDrop, a New Neighborhood Connection Platform, Across Canada
-
A New Era of Physical AI Senior & Dementia Care
-
Logista Advisors Announces Dismissal of CFTC Case With Prejudice
-
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform
-
Best’s Market Segment Report: AM Best Maintains Stable Outlook on Malaysia’s Non-Life Insurance Segment
-
Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease
-
Washington Launches New Tools to Help Medical Professionals Deliver Life-saving Medications for Opioid Use Disorder
-
Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger
-
Pembina Announces 2026 Guidance, Agreement for Cedar Capacity, and Business Update
-
nVent Increases Quarterly Dividend
-
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Creative Class Collective and the GRAMMY Museum® Reveal New Selena Mural by Artist Mister Toledo
-
GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Bios
-
Inovalis Real Estate Investment Trust Announces Distribution and Special Non-Cash Distribution to Unitholders
-
Independence Realty Trust Declares Fourth Quarter 2025 Dividend
-
Liberty Media Corporation Completes Split-Off of Liberty Live Holdings, Inc.
-
Aqua Pennsylvania Installs PFAS Treatment to Protect Drinking Water for Thousands of Customers in Bucks County
-
Cizzle Brands Corporation Releases its Fiscal Q1 2026 Results
-
PCI Government Services and Seekr Partner to Deploy Secure, Cost-Effective AI for Federal Agencies
-
RioCan Real Estate Investment Trust Announces December 2025 Distribution
-
Hercules Pharmaceuticals Appoints Ali Ahmed as Chief Commercial Officer
-
Centuri Releases 2025 Sustainability Report: Building Trust, Powering the Future
-
Windstar Cruises Takes Delivery of New All-Suite Yacht, Star Seeker
-
Pentair Announces 8 Percent Rate Increase to its Quarterly Cash Dividend and Authorizes New $1 Billion Share Repurchase Program
-
Hauppauge, NY Firm Joins Crete Professionals Alliance as Legacy Valuations & Forensics
-
Goldman Sachs Asset Management Announces Liquidation of Three Exchange-Traded Funds
-
Boise Cascade Completes Acquisition of Holden Humphrey
-
NYSE to Commence Delisting Proceedings with Respect to Warrants of BARK, Inc. (BARK WS)
-
Rhodes Ridge Joint Venture partners begin $191 million feasibility study on up to 50Mtpa Pilbara iron ore mine
-
JPMorganChase Declares Preferred Stock Dividends
-
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
-
Valvoline Inc. Survey Reveals What Drivers Will Face This Winter
-
Guardian Pharmacy Services, Inc. to Participate in Upcoming J.P. Morgan Healthcare Conference
-
BlackRock Corporate High Yield Fund, Inc. (HYT) Announces Terms of Rights Offering
-
Imperial provides 2026 corporate guidance outlook
-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer
-
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
-
Ark Restaurants Announces Financial Results for the Fourth Quarter and Fiscal Year Ended 2025
-
WM Announces Planned 14.5% Dividend Increase and $3 Billion Share Repurchase Authorization, Positioning the Company to Deliver Outsized Shareholder Returns in 2026

